Ceapro Inc.

TSXV:CZO Stock Report

Market Cap: CA$17.6m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Ceapro Management

Management criteria checks 3/4

Ceapro's CEO is Gilles Gagnon, appointed in Jan 2008, has a tenure of 16.42 years. total yearly compensation is CA$560.00K, comprised of 85.7% salary and 14.3% bonuses, including company stock and options. directly owns 1.9% of the company’s shares, worth CA$335.03K. The average tenure of the management team and the board of directors is 9.1 years and 9.2 years respectively.

Key information

Gilles Gagnon

Chief executive officer

CA$560.0k

Total compensation

CEO salary percentage85.71%
CEO tenure16.4yrs
CEO ownership1.9%
Management average tenure9.1yrs
Board average tenure9.2yrs

Recent management updates

Recent updates

Analysis Article • Aug 09

The Returns At Ceapro (CVE:CZO) Aren't Growing

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Analysis Article • Oct 15

Returns At Ceapro (CVE:CZO) Are On The Way Up

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Analysis Article • Jun 17

Ceapro's (CVE:CZO) Returns Have Hit A Wall

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
Analysis Article • Nov 19

Ceapro (CVE:CZO) Will Want To Turn Around Its Return Trends

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
Analysis Article • Jul 20

Be Wary Of Ceapro (CVE:CZO) And Its Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
Analysis Article • May 27

Ceapro's (CVE:CZO) Robust Earnings Are Supported By Other Strong Factors

Even though Ceapro Inc.'s ( CVE:CZO ) recent earnings release was robust, the market didn't seem to notice. Our...
Analysis Article • Apr 29

Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)

Does the April share price for Ceapro Inc. ( CVE:CZO ) reflect what it's really worth? Today, we will estimate the...
Analysis Article • Mar 01

Will Ceapro (CVE:CZO) Multiply In Value Going Forward?

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
Analysis Article • Feb 01

Is It Too Late To Consider Buying Ceapro Inc. (CVE:CZO)?

Ceapro Inc. ( CVE:CZO ), is not the largest company out there, but it saw a decent share price growth in the teens...
Analysis Article • Jan 06

Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)

Today we will run through one way of estimating the intrinsic value of Ceapro Inc. ( CVE:CZO ) by taking the expected...
Analysis Article • Nov 28

Ceapro Inc. (CVE:CZO) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Ceapro (CVE:CZO) has had a rough three months with its share price down 11%. But if you pay close attention, you might...

CEO Compensation Analysis

How has Gilles Gagnon's remuneration changed compared to Ceapro's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$5m

Sep 30 2023n/an/a

-CA$3m

Jun 30 2023n/an/a

-CA$759k

Mar 31 2023n/an/a

CA$2m

Dec 31 2022CA$560kCA$480k

CA$4m

Sep 30 2022n/an/a

CA$6m

Jun 30 2022n/an/a

CA$6m

Mar 31 2022n/an/a

CA$5m

Dec 31 2021CA$560kCA$480k

CA$3m

Sep 30 2021n/an/a

CA$2m

Jun 30 2021n/an/a

CA$844k

Mar 31 2021n/an/a

CA$1m

Dec 31 2020CA$507kCA$480k

CA$2m

Sep 30 2020n/an/a

CA$3m

Jun 30 2020n/an/a

CA$2m

Mar 31 2020n/an/a

CA$630k

Dec 31 2019CA$518kCA$480k

-CA$1m

Sep 30 2019n/an/a

-CA$855k

Jun 30 2019n/an/a

-CA$1m

Mar 31 2019n/an/a

-CA$657k

Dec 31 2018CA$555kCA$480k

-CA$316k

Sep 30 2018n/an/a

-CA$2m

Jun 30 2018n/an/a

-CA$2m

Mar 31 2018n/an/a

-CA$1m

Dec 31 2017CA$1mCA$480k

-CA$958k

Compensation vs Market: Gilles's total compensation ($USD410.93K) is above average for companies of similar size in the Canadian market ($USD176.99K).

Compensation vs Earnings: Gilles's compensation has been consistent with company performance over the past year.

CEO

Gilles Gagnon (70 yo)

16.4yrs
Tenure
CA$560,000
Compensation

Mr. Gilles R. Gagnon, M.Sc. MBA, ICD D, serves as Independent Director of Aeterna Zentaris Inc. since January 1, 2020. He serves as the President of Spectrum Pharma Canada Inc. (Spectrum Canada).Mr. Gagno...

Leadership Team

NamePositionTenureCompensationOwnership
Gilles Gagnon
CEO, President & Director16.4yrsCA$560.00k1.9%
CA$ 335.0k
Stacy Prefontaine
CFO & Corporate Secretary9.1yrsCA$232.99k0.042%
CA$ 7.3k
Bernhard Seifried
Senior Director of Research & Technologyno datano datano data
Michel Regnier
Senior Vice President of Technical Operations1.1yrsno datano data
9.1yrs
Average Tenure

Experienced Management: CZO's management team is seasoned and experienced (9.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gilles Gagnon
CEO, President & Director16.8yrsCA$560.00k1.9%
CA$ 335.0k
Genevieve Foster
Independent Director2.2yrsCA$92.38kno data
William Li
Independent Director9.6yrsCA$59.57k0.13%
CA$ 22.9k
Ronald Miller
Independent Chairman2.1yrsCA$96.06kno data
Ulrich Kosciessa
Independent Director9.2yrsCA$57.79k0.10%
CA$ 17.6k
9.2yrs
Average Tenure

Experienced Board: CZO's board of directors are considered experienced (9.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/06/03 10:08
End of Day Share Price 2024/06/03 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ceapro Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ahu DemirNOBLE Capital Markets, Inc.
Cosme OrdoñezNOBLE Capital Markets, Inc.